期刊文献+

卵巢性索间质肿瘤中Ki67的表达及临床意义

下载PDF
导出
摘要 目的:探讨卵巢性索间质肿瘤中增殖细胞相关核抗原(Ki67)的表达及意义。方法:采用免疫组化En-Vision二步法检测Ki67在48例卵巢性索间质肿瘤中的表达,并分析与临床病理参数的关系。结果:卵巢颗粒细胞瘤组织中Ki67表达高于卵泡膜细胞瘤和正常对照组,差异有显著性(P<0.05);在卵巢颗粒细胞瘤随临床分期升高Ki67表达水平增强(P<0.05);核分裂相≥3/HPF明显高于核分裂相<3/HPF(P<0.05);复发者Ki67表达高于原发者(P<0.05)。结论:卵巢性索间质肿瘤中Ki67表达与临床分期、组织学类型有关,检测Ki67表达对卵巢性索间质肿瘤的生物学行为判断及预后估计具有重要意义。
出处 《山西职工医学院学报》 CAS 2009年第1期11-13,共3页 Journal of Shanxi Medical College for Continuing Education
  • 相关文献

参考文献9

  • 1宋和存,向征,李慧.Survivin Ki67在卵巢原发癌与转移癌中的表达及其临床意义[J].中国实用妇科与产科杂志,2006,22(3):201-203. 被引量:8
  • 2任琼珍,钱志红,胡建铭.Ki67在卵巢癌中的表达及临床意义[J].苏州大学学报(医学版),2006,26(2):321-321. 被引量:9
  • 3Stefansson IM,Salvesen HB,Immervoll H,et al. Prognostic impact of histological grade and vascular invasion compared with tumour cell proliferation in endometrial carcinoma of endometrioid type[ J]. Histopathology, 2004,44 ( 5 ) :472-479.
  • 4KAERN J,TROPE C,A GHMESHEH M,et al. A study of prognostic parameters predicting long-term survival in stage Ⅲ epithelial ovarian cancer[J]. Int J Gancer,2004,14( 1 ) :60-66.
  • 5Concin N, Hefler L,van Bavel J,et al. Biological markers in pT1 and pT2 ovarian cancer with lymph node metastaces [ J ]. Gyneeol Oncol, 2003,89( 1 ) ;9-15.
  • 6Bar JK,Grelewski P,Popiela A,et al. Type Ⅳ collagen and CD44v6 expression in benign, malignant primal' and metastatic ovarian tumors;correlation with Ki67 and p53 immunoreactivity [ J ]. Gynecol Oncol,2004,95 ( 1 ) :23-31.
  • 7Costa MJ ,Walls J ,Ames P ,et al. Transformation in recurrent ovarian granulosa cell tumors: Ki67 (MIBI) and p53 immunohistochemistry demonstrates a possible molecular basis for the poor histoputhologie prediction of clinical behavior[ J] . Hum Pathol , 1996 ,27 (3) :274 -281.
  • 8S. F. Adams, D. A. Levine,etal. Ki67 expression as a predictor for suboptimally debulked patients with advanced epithelial ovarian cancer[ J]. Journal of Clinical Oncology, 2007, 25 (18S) : 55-63.
  • 9刘培淑,李爱华,董瑞英,孙丽美.Ki67抗原在卵巢肿瘤组织中的表达及与临床病理参数的关系[J].现代妇产科进展,2001,10(5):362-363. 被引量:7

二级参考文献19

  • 1钱洪流,宗永生,张昌卿.鼻咽癌中p53蛋白积聚的生物学特征和临床意义[J].临床与实验病理学杂志,1996,12(1):15-18. 被引量:20
  • 2Duchrow M,Schluter C,Key G,et al.Cell proliferation associated nuclear antigen defined by antibody ki67:a new kind of cyclemaintaining proteins[J].Arch Immunol Ther Exp,1995,43 (2):117-118.
  • 3Wong FW.Immunohistochemical antibody ki67[J].Gynecol Obstet,1994,37 (2):123-124.
  • 4Garzetti GG,Ciavattini A,Goteri G.Ki67 antigen immune staining (MIB1 monoclonal antibody) in serous ovarian tumors:index of proliferative activity with prognostic significance[J].Gynecol Oncol,1995,56(2):169-174.
  • 5Matsuta M,Kimura S,Kosegawa G.Immunohistochemical detection of ki67 in epithelial skin tumors in formalin-fixed paraffinembedded tissue sections using a new monoclonal antibody(MIB-1)[J].J Dermatol,1996,23 (3):147-152.
  • 6Korkolopoulou P,Vassilopoulos I,Konstantinidou AE,et al.The combined evaluation of p27kip1 and ki67 expression provides independent information on overall survival of ovarian carcinoma patients[J].Gynecol Oncol,2002,85 (3):404-414.
  • 7Li F,Ambrosini G,Chu EY,et al.Control of apoptosis and mitotic spindle checkpoint by surviving[J].Nature,1998,396(6711):580-584.
  • 8Altieri DC.The molecular basis and potential role of survivin cancer diagnosis and therapy[J].Trend Mol Med,2001,7(12):542-547.
  • 9Schluter C,Duchrow W,Woblenberg C,et al.The cell proliferation associated antibody ki67:a very large uniquitous nuclear protein with numerous repeated elements representing a new kind of cell cycle-maintaining proteins[J].J Cell Biol,1993,23 (11):513-522.
  • 10McCormick D,Yu C,Hobbs C,et al.The relevance of antibody conecentration to the immunohistological quantiation of cell proliferation associated antigens[J].Histoparthology,1993,22:543-547.

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部